Peter D. Haytaian

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ELV

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$950,000	—	$3,840,306	$1,199,710	$986,100	$122,372	$7,098,488
2024	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$950,000	—	$3,600,081	$1,199,997	$406,980	$188,069	$6,345,127
2023	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$944,231	—	$3,225,051	$1,074,976	$1,314,369	$419,424	$6,978,051
2022	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$919,231	—	$3,000,218	$999,871	$1,323,692	$144,717	$6,387,729
2021	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$890,385	—	$4,125,385	$1,374,662	$1,375,111	$123,315	$7,888,858
2020	Elevance Health, Inc. (ELV)	EVP and President, Carelon and CarelonRx	$845,192	—	$2,437,632	$812,385	$1,183,269	$108,633	$5,387,111
2019	Elevance Health, Inc. (ELV)	EVP and President, Diversified Business Group and IngenioRx	$820,192	—	$2,437,749	$812,264	$902,211	$104,550	$5,076,966

No earnings-call appearances or filed executive changes recorded yet.